Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial

Post time 2022-5-9 01:41:32

Hello everyone could you help me with this one ? Thanks !

DOI:10.1016/S1474-4422(20)30494-4

Article link: https://pubmed.ncbi.nlm.nih.gov/33743237/

Article author:

Remark:

Post time 2022-5-9 01:41:33

: This post has been completed
Completed attachments will be deleted within 24 hours.

[JAMA] Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[JAMA] Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[JAMA] Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial